Jeffrey BaumelPartner at Dentons
Jeffrey Baumel heads the US securities practice and co-leads the Firm's Life Sciences and Health Care industry sector, representing a broad range of companies in the life sciences, biotechnology and technology industries. His deep securities law experience comes from working with issuers, underwriters and venture capital investors on a wide range of transactions. These have included public offerings and private placements of equity and debt securities involving hundreds of millions of US dollars. In addition, Jeffrey has worked extensively with venture capital and investment banking firms specializing in growth-stage ventures.
Jeffrey advises boards of directors on complex corporate governance and compliance matters. He also represents both public and private companies in connection with corporate and commercial transactions, including mergers and acquisitions. A chair of the BioNJ Venture Capital Forum, Jeffrey also speaks regularly on issues relating to finance, corporate governance and securities law.